| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $33.6B | $21.7B | $17.7B | $22.4B | $16.5B | $2.6B | $2.7B | $3.1B |
| Cost of Revenue | $23.4B | $13.3B | $11.9B | $17.9B | $12.3B | $5.1B | $6.8B | $9.4B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $5.7B | $5.0B | $4.1B | $2.8B | $2.6B | $0.5B | $0.5B | $1.8B |
| Net Income | $3.4B | $3.0B | $2.7B | $1.7B | $1.5B | $0.6B | $1.3B | $0.3B |
| EPS (Basic) | $5.43 | $5.19 | $5.49 | $3.85 | $3.36 | $0.69 | $0.77 | $0.71 |
| EPS (Diluted) | $5.42 | $5.17 | $5.48 | $3.84 | $3.35 | $0.69 | $0.77 | $0.70 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $66.6B | $64.1B | $44.3B | $24.4B | $23.6B | $23.1B | $21.8B | $18.2B |
| Current Assets | $4.5B | $4.2B | $3.1B | $2.5B | $2.4B | $1.9B | $1.5B | $1.4B |
| Cash & Equivalents | $0.1B | $0.7B | $0.3B | $0.2B | $0.1B | $0.5B | $0.0B | $0.0B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $6.4B | $4.7B | $3.5B | $3.1B | $3.2B | $1.3B | $2.0B | $2.1B |
| Stockholders' Equity | $22.5B | $17.0B | $16.5B | $6.5B | $6.0B | $6.0B | $6.2B | $6.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $5.6B | $4.9B | $4.4B | $2.9B | $2.5B | $1.9B | $1.9B | $2.2B |
| Investing Cash Flow | $-3.8B | $-6.6B | $-6.4B | $-1.1B | $-0.7B | $-2.3B | $-3.8B | $-2.1B |
| Capital Expenditures | $3.2B | $2.0B | $1.6B | $1.2B | $0.7B | $2.2B | $3.8B | $2.1B |
| Financing Cash Flow | $-2.5B | $2.1B | $2.1B | $-1.7B | $-2.3B | $0.9B | $1.8B | $-0.1B |